Polymedica Corp - Current report filing (8-K)

Table of Contents

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 5, 2007

POLYMEDICA CORPORATION

(Exact Name of Registrant as Specified in Charter)

Massachusetts		0-19842		04-3033368
(State or Other Jurisdiction of Incorporation		(Commission File Number)		(IRS Employer Identification No.)

701 Edgewater Road, Suite 360 Wakefield, Massachusetts		01880
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: [phone]

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
þ		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

TABLE OF CONTENTS

	Item 8.01. Other Events
SIGNATURE

---

Table of Contents

Item 8.01. Other Events

In connection with the proposed transaction between PolyMedica Corporation and Medco Health Solutions, Inc., the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired at 11:59 p.m. on October 5, 2007.

2

---

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	POLYMEDICA CORPORATION
Date: October 9, 2007	By:	/s/ Devin J. Anderson
		Devin J. Anderson
		Executive Vice President, General Counsel and Secretary

3